Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1376690271
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5915 W Memorial Rd, Suite 200
Oklahoma City, OK, 73142
Phone (405) 773-6400
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
936 services
Medicare patients, 2024
445
Average age 73
Drug cost, 2024
$1.5M
1,543 prescriptions
Company payments, 2025
$1,202
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lara Theobald was code 99214 (office e&m - established), 428 times for 287 patients. In total Lara Theobald billed 936 services in 15 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 428 | 287 | $61.86 | $26K |
| 99215 Office E&M - Established | Office | 221 | 128 | $102.69 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 66 | 30 | $57.70 | $3,809 |
| 99213 Office E&M - Established | Office | 61 | 59 | $44.07 | $2,688 |
| 99205 Office E&M - New | Office | 51 | 51 | $118.36 | $6,036 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 18 | $88.30 | $2,914 |
| 99231 Hospital E&M - Subsequent | Facility | 26 | 16 | $35.31 | $918 |
| 99223 Hospital E&M - Initial | Facility | 21 | 20 | $118.31 | $2,485 |
By year: 2022 $69K for 950 services; 2023 $65K for 859 services; 2024 $70K for 936 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lara Theobald prescribed most often to Medicare patients was Anastrozole, with 416 prescriptions and refills. In total Lara Theobald wrote 1,543 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 416 | 1,133 | 123 | $14K |
| Letrozole Generic | 137 | 350 | 37 | $2,750 |
| Ibrance Palbociclib | 53 | 53 | Under 11 | $815K |
| Gabapentin Generic | 47 | 56 | Under 11 | $569 |
| Veozah Fezolinetant | 46 | 48 | Under 11 | $25K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 44 | 44 | 23 | $1,118 |
| Exemestane Generic | 44 | 92 | 12 | $3,831 |
| Potassium Chloride Generic | 36 | 54 | Under 11 | $413 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 34 | 52 | Under 11 | $592 |
| Ibandronate Sodium Generic | 31 | 62 | Under 11 | $795 |
| Tamoxifen Citrate Generic | 31 | 89 | Under 11 | $1,229 |
| Alendronate Sodium Generic | 30 | 53 | Under 11 | $207 |
| Pregabalin Generic | 24 | 24 | Under 11 | $257 |
| Eliquis Apixaban | 22 | 32 | Under 11 | $14K |
| Ondansetron Odt Ondansetron | 22 | 22 | 17 | $268 |
Brand drugs: 199 claims; generic drugs: 1,344 claims; opioid claims: 105.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lara Theobald $1,202 ($1,202 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,000.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.